Question 1

What are the potential side effects of the CD19/CD20 dual-target CAR-T cell therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have for my lymphoma?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the process of receiving CAR-T cell therapy involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dual Target CAR-T Cells in B-cell Lymphoma clinical trial (NCT04723914). Contact the study team or your healthcare provider for specific answers.

What this study is about